Cargando…

Sarcopenia in Chronic Kidney Disease: Focus on Advanced Glycation End Products as Mediators and Markers of Oxidative Stress

Sarcopenia is common in chronic kidney disease (CKD), and it is independently associated with morbidity and mortality. Advanced glycation end products (AGE) are mainly known as aging products. In CKD, AGE accumulate due to increased production and reduced kidney excretion. The imbalance between oxid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dozio, Elena, Vettoretti, Simone, Lungarella, Giuseppe, Messa, Piergiorgio, Corsi Romanelli, Massimiliano M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8068965/ https://www.ncbi.nlm.nih.gov/pubmed/33918767 http://dx.doi.org/10.3390/biomedicines9040405

Ejemplares similares

Association between Advanced Glycation End-Products and Sarcopenia in Patients with Chronic Kidney Disease
por: Molinari, Paolo, et al.
Publicado: (2022)

Advanced Glycation End Products (AGE) and Soluble Forms of AGE Receptor: Emerging Role as Mortality Risk Factors in CKD
por: Dozio, Elena, et al.
Publicado: (2020)

Accelerated AGEing: The Impact of Advanced Glycation End Products on the Prognosis of Chronic Kidney Disease
por: Dozio, Elena, et al.
Publicado: (2023)

Glycation and Glycosylation in Cardiovascular Remodeling: Focus on Advanced Glycation End Products and O-Linked Glycosylations as Glucose-Related Pathogenetic Factors and Disease Markers
por: Dozio, Elena, et al.
Publicado: (2021)

In Patients with Chronic Kidney Disease Advanced Glycation End-Products Receptors Isoforms (sRAGE and esRAGE) Are Associated with Malnutrition
por: Caldiroli, Lara, et al.
Publicado: (2022)

Association of Autofluorescent Advanced Glycation End Products (AGEs) with Frailty Components in Chronic Kidney Disease (CKD): Data from a Single-Center Cohort Study
por: Molinari, Paolo, et al.
Publicado: (2023)

AGEs and sRAGE Variations at Different Timepoints in Patients with Chronic Kidney Disease
por: Molinari, Paolo, et al.
Publicado: (2021)

Role of the Soluble Receptor for Advanced Glycation End Products (sRAGE) as a Prognostic Factor for Mortality in Hemodialysis and Peritoneal Dialysis Patients
por: Dozio, Elena, et al.
Publicado: (2018)

Soluble Receptor for Advanced Glycation End Products: A Protective Molecule against Intramyocardial Lipid Accumulation in Obese Zucker Rats?
por: Dozio, Elena, et al.
Publicado: (2019)

Expression of the Receptor for Advanced Glycation End Products in Epicardial Fat: Link with Tissue Thickness and Local Insulin Resistance in Coronary Artery Disease
por: Dozio, Elena, et al.
Publicado: (2016)

Sarcopenia is Associated with Malnutrition but Not with Systemic Inflammation in Older Persons with Advanced CKD
por: Vettoretti, Simone, et al.
Publicado: (2019)

Soluble Receptor for Advanced Glycation End Products and Its Forms in COVID-19 Patients with and without Diabetes Mellitus: A Pilot Study on Their Role as Disease Biomarkers
por: Dozio, Elena, et al.
Publicado: (2020)

Association of Sarcopenia and Gut Microbiota Composition in Older Patients with Advanced Chronic Kidney Disease, Investigation of the Interactions with Uremic Toxins, Inflammation and Oxidative Stress
por: Margiotta, Elisabetta, et al.
Publicado: (2021)

Association of advanced glycation end products with sarcopenia and frailty in chronic kidney disease
por: Yabuuchi, Junko, et al.
Publicado: (2020)

Frailty phenotype and multi-domain impairments in older patients with chronic kidney disease
por: Vettoretti, Simone, et al.
Publicado: (2020)

Low heart-type fatty acid binding protein level during aging may protect down syndrome people against atherosclerosis
por: Vianello, Elena, et al.
Publicado: (2013)

Skin Autofluorescence, a Noninvasive Biomarker for Advanced Glycation End-products, Is Associated With Sarcopenia
por: Waqas, Komal, et al.
Publicado: (2021)

Diagnostic Values of Advanced Glycation End Products and Homocysteine in Patients with Alzheimer's Disease and Sarcopenia
por: Zhang, Xuelian, et al.
Publicado: (2022)

Plasmatic Soluble Receptor for Advanced Glycation End Products as a New Oxidative Stress Biomarker in Patients with Prosthetic-Joint-Associated Infections?
por: Massaccesi, Luca, et al.
Publicado: (2017)

Gut microbiota composition and frailty in elderly patients with Chronic Kidney Disease
por: Margiotta, Elisabetta, et al.
Publicado: (2020)

Elevated level of the soluble receptor for advanced glycation end-products involved in sarcopenia: an observational study
por: Wu, Shou-En, et al.
Publicado: (2021)

Osteopontin: The Molecular Bridge between Fat and Cardiac–Renal Disorders
por: Vianello, Elena, et al.
Publicado: (2020)

Intra-erythrocytes magnesium deficiency could reflect cognitive impairment status due to vascular disease: a pilot study
por: Sitzia, Clementina, et al.
Publicado: (2020)

A Wide-Proteome Analysis to Identify Molecular Pathways Involved in Kidney Response to High-Fat Diet in Mice
por: Dozio, Elena, et al.
Publicado: (2022)

Vitamin D and Calcium Supplementation and Urolithiasis: A Controversial and Multifaceted Relationship
por: Messa, Piergiorgio, et al.
Publicado: (2023)

Native Hypovitaminosis D in CKD Patients: From Experimental Evidence to Clinical Practice
por: Alfieri, Carlo, et al.
Publicado: (2019)

Nutritional Strategies to Prevent Muscle Loss and Sarcopenia in Chronic Kidney Disease: What Do We Currently Know?
por: Massini, Giulia, et al.
Publicado: (2023)

Calcium and Osteoprotegerin Levels Predict the Progression of the Abdominal Aortic Calcifications After Kidney Transplantation
por: Meneghini, Maria, et al.
Publicado: (2013)

Glycated Albumin for Glycemic Control in T2DM Population: A Multi-Dimensional Evaluation
por: Ferrario, Lucrezia, et al.
Publicado: (2021)

Irisin: A Potential Link between Physical Exercise and Metabolism—An Observational Study in Differently Trained Subjects, from Elite Athletes to Sedentary People
por: Benedini, Stefano, et al.
Publicado: (2017)

PCSK9 Expression in Epicardial Adipose Tissue: Molecular Association with Local Tissue Inflammation
por: Dozio, Elena, et al.
Publicado: (2020)

Increased Levels of sRAGE in Diabetic CKD-G5D Patients: A Potential Protective Mechanism against AGE-Related Upregulation of Fibroblast Growth Factor 23 and Inflammation
por: Dozio, Elena, et al.
Publicado: (2017)

Association of accumulated advanced glycation end‐products with a high prevalence of sarcopenia and dynapenia in patients with type 2 diabetes
por: Mori, Hiroyasu, et al.
Publicado: (2019)

Advanced Glycation End Products and Psoriasis
por: Maurelli, Martina, et al.
Publicado: (2023)

Correlation of Dietary Advanced Glycation End Products with the Hematological and Biochemical Markers of Patients with Chronic Kidney Disease Undergoing Hemodialysis
por: Aroni, Adamantia, et al.
Publicado: (2019)

The Role of Advanced Glycation End Products and Its Soluble Receptor in Kidney Diseases
por: Steenbeke, Mieke, et al.
Publicado: (2022)

Advanced Glycation End Products and Bone Metabolism in Patients with Chronic Kidney Disease
por: Quadros, Kélcia R. S., et al.
Publicado: (2023)

Vitamin D Deficiency Is Associated with Increased Osteocalcin Levels in Acute Aortic Dissection: A Pilot Study on Elderly Patients
por: Vianello, Elena, et al.
Publicado: (2017)

Possible Benefits of a Low Protein Diet in Older Patients With CKD at Risk of Malnutrition: A Pilot Randomized Controlled Trial
por: Caldiroli, Lara, et al.
Publicado: (2022)

Receptor for Advanced Glycation End Products (RAGE) and Its Ligands: Focus on Spinal Cord Injury
por: Song, Juhyun, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6q6369eo5cjg0m6fhah13iac4p